{
    "id": "dbpedia_7491_3",
    "rank": 66,
    "data": {
        "url": "https://www.bloomberg.com/news/articles/2020-08-26/operation-warp-speed-hedges-bets-on-different-vaccine-platforms",
        "read_more_link": "",
        "language": "en",
        "title": "Operation Warp Speed Hedges Bets on Different Vaccine Platforms",
        "top_image": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iyO1svmHyp7c/v1/1200x800.jpg",
        "meta_img": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iyO1svmHyp7c/v1/1200x800.jpg",
        "images": [
            "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iyO1svmHyp7c/v1/-1x-1.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "SPEED",
            "Coronavirus",
            "White House",
            "MERCK & CO",
            "Department of Defense",
            "Government",
            "NEW ENGLAND JOURNAL OF MEDIC",
            "JOHNSON & JOHNSON",
            "MODERNA INC",
            "PFIZER INC",
            "business",
            "politics",
            "technology",
            "prognosis"
        ],
        "tags": null,
        "authors": [
            "Riley Griffin"
        ],
        "publish_date": "2020-08-26T00:00:00",
        "summary": "",
        "meta_description": "The White House has secured eight experimental coronavirus vaccines through its “Operation Warp Speed” effort, seeking to hedge its bets on different technologies, according to a top adviser to the program.",
        "meta_lang": "en",
        "meta_favicon": "https://www.bloomberg.com/favicon-black.png",
        "meta_site_name": "Bloomberg.com",
        "canonical_link": "https://www.bloomberg.com/news/articles/2020-08-26/operation-warp-speed-hedges-bets-on-different-vaccine-platforms",
        "text": "The White House has secured eight experimental coronavirus vaccines through its “Operation Warp Speed” effort, seeking to hedge its bets on different technologies, according to a top adviser to the program.\n\nMoncef Slaoui , the operation’s chief adviser, and Matthew Hepburn, a Department of Defense official, outlined the federal criteria for selecting and securing vaccine candidates in an essay in the New England Journal of Medicine on Wednesday."
    }
}